FMP
Agilent Technologies, Inc.
A
NYSE
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
121.18 USD
3.85 (3.18%)
Mr. Padraig McDonnell
Healthcare
Medical - Diagnostics & Research
NYSE
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imag...
0001090872
US00846U1016
00846U101
5301 Stevens Creek Boulevard
800 227 9770
US
17,900
Nov 18, 1999
0001090872
NYSE
Medical - Diagnostic...
Healthcare
00846U101
US00846U1016
US
121.18
1.11
1.81M
34.55B
-
117.17-155.35
85.55
-
-
-
-
27.79
-
https://www.agilent.com
We are unable to load the data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Rayan Ahmad
13 hours ago
Bayerische Motoren Werke AG, known as BMW, is a leading German automobile manufacturer. Trading under the symbol BAMXF on the PNK exchange, BMW is renowned for its luxury vehicles and motorcycles. The company faces competition from other automotive giants like Mercedes-Benz and Audi. Despite its strong brand presence, BMW is currently navigating financial challenges. On March 14, 2025, BMW reported earnings per share of $2.49, missing the estimated $3.73. The company's revenue was approximately...
Alex Lavoie
13 hours ago
Genmab A/S, trading under the symbol NASDAQ:GMAB, is a biotechnology company known for its innovative antibody therapeutics. Established in 1999 and based in Copenhagen, Denmark, Genmab focuses on developing next-generation antibody technology platforms. The company aims to make a significant impact on the lives of people with cancer and other serious diseases by 2030. In compliance with Article 19 of Regulation No. 596/2014 on Market Abuse, Genmab has disclosed share transactions by its manage...
Davit Kirakosyan
14 hours ago
Semtech (NASDAQ:SMTC) surged around 18% intra-day today after reporting better-than-expected fourth-quarter results, fueled by rising demand for AI and machine learning applications that drove data center sales and improved margins. For the quarter, the semiconductor and cloud services provider posted adjusted earnings per share of $0.40, beating analyst expectations of $0.33. Revenue reached $251 million, slightly exceeding the forecasted $250.18 million. Semtech also saw significant margin exp...
Davit Kirakosyan
14 hours ago
Ulta Beauty (NASDAQ:ULTA) shares surged nearly 12% intra-day today after the cosmetics retailer posted better-than-expected fourth-quarter earnings, driven by strong demand during the holiday season. However, weaker-than-anticipated full-year guidance raised concerns about the impact of economic headwinds on consumer spending. The company reported earnings per share of $8.46 on revenue of $3.5 billion, surpassing analyst expectations of $7.11 EPS and $3.46 billion in revenue. Comparable sales ro...
Davit Kirakosyan
15 hours ago
DocuSign (NASDAQ:DOCU) delivered a better-than-expected fourth-quarter earnings report, pushing its stock up over 18% intra-day today. The company posted earnings per share of $0.86, slightly outperforming analyst expectations of $0.84. Revenue for the quarter also exceeded forecasts, reaching $776.3 million, above the $760.99 million consensus estimate. Despite the strong quarter, DocuSign’s outlook for fiscal 2026 came in softer than anticipated. The company expects first-quarter revenue betw...
Rayan Ahmad
18 hours ago
AirSculpt Technologies, Inc. (NASDAQ:AIRS) is a prominent player in the body contouring industry, known for its innovative and minimally invasive procedures. The company operates 32 centers worldwide and has performed over 70,000 procedures. Despite its strong market presence, AIRS faces stiff competition from other cosmetic surgery providers. The company recently reported its financial results for the fourth quarter and full year ending December 31, 2024. On March 14, 2025, AIRS announced an e...
Alex Lavoie
18 hours ago
Science Applications International Corporation (NASDAQ: SAIC) is a prominent player in the technology integration sector, known for its innovative solutions. As a Fortune 500 company, SAIC focuses on leveraging technology to deliver comprehensive solutions. The company is set to release its fourth-quarter fiscal year 2025 results on March 17, 2025, before the market opens, with a conference call scheduled at 10:00 a.m. Eastern Time. Wall Street anticipates SAIC's earnings per share to be $2, wi...
Alex Lavoie
20 hours ago
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases. The company is known for its product, WAKIX, which is used to treat excessive daytime sleepiness in adults with narcolepsy. In the competitive landscape, Harmony stands out due to its effective capital utilization, as evidenced by its financial metrics. Harmony Biosciences showcases a Return on Invested Capit...